- This event has passed.
Recent Content
- Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study
- KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway
- Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice
- FDA Approval Summary: Ciltacabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma
- Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma
- Understanding health outcome preferences of older adults diagnosed with multiple myeloma
- The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans
- CAR T cells in multiple myeloma: lessons learned
- The evolving pattern of the monoclonal protein improves the IMWG 2/20/20 classification for patients with smoldering multiple myeloma
- Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping